From xanthine oxidase inhibition to inflammasome regulation: exploring the potential role of allopurinol in TXNIP–NLRP3 signaling and pyroptosis in diabetes
Aug 2026· InflammoPharmacology· Vol 34, pp. 5901 - 5917· 0 citations· 107 references
Medicine
TL;DR
Current evidence supporting the potential role of allopurinol as an upstream modulator of inflammasome activation is critically evaluated, with particular emphasis on the emerging and underexplored field of diabetic osteopathy.
This study signifies the mechanisms underlying circadian regulation of the P2X7–NLRP3 axis, its tissue-specific roles in obesity, and available preclinical and clinical evidence, and further review innovative therapeutics like inflammatory inhibiting targets including inflammasome inhibitors, P2X7 antagonists and chron...
Pyroptosis, a Gasdermin‐dependent inflammatory form of programmed cell death, has been implicated in DKD progression and metformin has shown renoprotective effects in DKD; however, the underlying mechanisms remain unclear.
Shu-Yu Shi, Bing Wang, Yang Zhou et al.· Diabetes, obesity and metabo...· 0 citations
The proposed ferroptosis–pyroptosis–NRF2 network should be viewed as a biologically plausible integrative framework rather than a clinically validated linear pathway.
Ana María García-Muñoz, Desirée Victoria-Montesinos, Juana M. Morillas-Ruiz· Nutrients· 0 citations
Atherosclerosis is an age-related immune-metabolic disease in which lipid retention, endothelial dysfunction, innate immune activation, and vascular remodeling interact over decades. In older adults, inflammaging, mitochondrial dysfunction, defective autophagy/mitophagy, and cellular senescence may lower the threshold...
Yelizaveta A. Marakhovskaya, Ksenia A. Eruslanova, O. Maltseva et al.· Biomolecules· 0 citations
A novel perspective on the inflammatory mechanisms underlying diabetes mellitus and its complications is provided, thereby establishing a theoretical foundation for the development of therapeutic strategies centered on modulating the cGAS-STING pathway.
Guang-Dong Qi, Tong-Xin Shang, Hua-Lin Sun et al.· Frontiers in Pharmacology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.